AirSeal is one of the finalists competing for the Arch Grants 2023. - AirSeal CardioVascular

AirSeal is one of the finalists competing for the Arch Grants 2023.

Releted Post

AirSeal is selected as a recipient of the first WashU Venture Network Follow-on Investments

April 12, 2025

Our co-founder, Dr. Zayed, was recently interviewed by KMOX Radio

April 1, 2025

AirSeal is awarded a co-investment of $500,000 from Missouri Technology Corporation (MTC)

November 12, 2024

AirSeal is selected as a 2024 Arch Grants recipient, which includes a $75,000 non-dilutive cash award.

November 1, 2024

AirSeal is one of the finalists competing for the Arch Grants 2023.

AirSeal is advancing early, accurate diagnosis of cardiovascular diseases through innovative biomarker technology.

© 2023-2025 by AirSeal CardioVascular Inc. Designed & Developed by Steatech